- Home
- LEXX vs CYN Comparison
LEXX vs CYN Comparison
Compare LEXX & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- CYN
- Stock Information
- Founded
- LEXX 2004
- CYN 2013
- Country
- LEXX Canada
- CYN United States
- Employees
- LEXX N/A
- CYN N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- CYN EDP Services
- Sector
- LEXX Health Care
- CYN Technology
- Exchange
- LEXX Nasdaq
- CYN Nasdaq
- Market Cap
- LEXX 22.7M
- CYN 22.7M
- IPO Year
- LEXX N/A
- CYN 2021
- Fundamental
- Price
- LEXX $1.13
- CYN $3.66
- Analyst Decision
- LEXX Strong Buy
- CYN
- Analyst Count
- LEXX 1
- CYN 0
- Target Price
- LEXX $4.00
- CYN N/A
- AVG Volume (30 Days)
- LEXX 212.4K
- CYN 228.2K
- Earning Date
- LEXX 01-09-2026
- CYN 11-18-2025
- Dividend Yield
- LEXX N/A
- CYN N/A
- EPS Growth
- LEXX N/A
- CYN N/A
- EPS
- LEXX N/A
- CYN N/A
- Revenue
- LEXX $615,923.00
- CYN $457,227.00
- Revenue This Year
- LEXX $46.98
- CYN $31.96
- Revenue Next Year
- LEXX $17.26
- CYN $1,459.25
- P/E Ratio
- LEXX N/A
- CYN N/A
- Revenue Growth
- LEXX 49.85
- CYN 347.74
- 52 Week Low
- LEXX $0.77
- CYN $2.62
- 52 Week High
- LEXX $2.85
- CYN $1,121.99
- Technical
- Relative Strength Index (RSI)
- LEXX 57.12
- CYN 43.64
- Support Level
- LEXX $1.00
- CYN $2.76
- Resistance Level
- LEXX $1.19
- CYN $3.60
- Average True Range (ATR)
- LEXX 0.08
- CYN 0.33
- MACD
- LEXX -0.00
- CYN 0.03
- Stochastic Oscillator
- LEXX 66.25
- CYN 62.91
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.